Concord Pharmaceuticals Ltd., Bangladesh launched Dapazin for the first time with the collaboration with Zar & Zar Co., Ltd in Hotel Melia Yangon, Myanmar.
It was officially opened by Prof. Tint SweLatt President, Myanmar Diabetic Association (MMDI) and highlighted how revolutionary Dapagliflozin in the field of medicine and the current global concern of SGLT-2 Inhibitor in managing Type-2 diabetes. He emphasized that every county can play a role by preventing and managing this disease, and promoting prudent use of oral Anti diabetic drugs (OAD).
The ceremony was officially closed by DrMyo Thant (President, Zar&Zar Co. ltd) who emphasized on the national action plan and the importance of this drug and their impact on the health approach, which is only possible through working together.

Share

Leave a comment

Your email address will not be published. Required fields are marked *

top
© Copyright 2021. All Right reserved.
Designed and Developed by Ripple Intra